Myriad Genetics
MYGN
MYGN
280 hedge funds and large institutions have $3.96B invested in Myriad Genetics in 2014 Q1 according to their latest regulatory filings, with 59 funds opening new positions, 67 increasing their positions, 131 reducing their positions, and 46 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
49% less repeat investments, than reductions
Existing positions increased: 67 | Existing positions reduced: 131
57% less call options, than puts
Call options by funds: $74.4M | Put options by funds: $174M
Holders
280
Holding in Top 10
7
Calls
$74.4M
Puts
$174M
Top Buyers
| 1 | +$141M | |
| 2 | +$109M | |
| 3 | +$87.8M | |
| 4 |
CCM
Consonance Capital Management
New York
|
+$59.6M |
| 5 |
SCM
Scopia Capital Management
New York
|
+$53.6M |
Top Sellers
| 1 | -$58.6M | |
| 2 | -$50.7M | |
| 3 | -$48.1M | |
| 4 |
MCM
Munder Capital Management
Birmingham,
Michigan
|
-$33.3M |
| 5 |
SGAM
Smith Group Asset Management
Dallas,
Texas
|
-$25.6M |